BAN ORL 24 dihydrochloride

CAS No. 1401463-54-4

BAN ORL 24 dihydrochloride( —— )

Catalog No. M32796 CAS No. 1401463-54-4

BAN ORL 24 is a highly potent nociceptin/orphan FQ (N/OFQ) receptor (NOP) antagonist that can be used to study neurological diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BAN ORL 24 dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    BAN ORL 24 is a highly potent nociceptin/orphan FQ (N/OFQ) receptor (NOP) antagonist that can be used to study neurological diseases.
  • Description
    BAN ORL 24 is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. BAN ORL 24 has antagonistic effect for nociceptin (NOP) receptor with KI value of 0.24 nM in CHO cell. BAN ORL 24 can be used for the research of cancer and analgesic.
  • In Vitro
    BAN ORL 24 has antagonist for NOR and MOR (opioid receptor subtype) with IC50 values of 50 μM and 0.224 μM, respectively.
  • In Vivo
    BAN ORL 24 (10 mg/kg; i.v.) attenuates the duration of BPRIM97 thermal antinociception.Animal Model:C57BL/6 mice Dosage:10 mg/kg Administration:10 mg/kg; i.v.Result:Caused inhibition of BPRIM97-induced antinociception at 90-min post injection.Did not attenuate BPR1M97-induced antinociception in the tail-clip test after 30 min.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1401463-54-4
  • Formula Weight
    506.51
  • Molecular Formula
    C27H37Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (394.86 mM; Ultrasonic ) H2O : 100 mg/mL (197.43 mM; Ultrasonic)
  • SMILES
    O=C([C@@H]1N(CCC1)CC2=CC=CC=C2)NCCCN3CCC4(CC3)C5=CC=CC=C5CO4.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fischetti et al (2009) Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist compound 24. Eur.J.Pharmacol. 614 50.?
molnova catalog
related products
  • Alvimopan

    A selective peripherally acting μ-opioid antagonist with IC50 of 1.7 nM for the treatment of postoperative ileus.

  • UFP-101

    Potent, selective and competitive silent antagonist for the NOP opioid receptor. Binds to NOP with high affinity (pKi = 10.24) and displays > 3000-fold selectivity over δ, μ and κ opioid receptors. Antinociceptive and opposes the action of nociceptin in vivo.

  • DPDPE TFA

    DPDPE TFA is selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo.